Best Small Cell Lung Cancer Treatment Podcasts (2025)

1
S2 Ep46: Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer 34:53

Play Pause

28d ago34:53

34:53

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Benjamin P. Levy, MD; Ticiana Leal, MD; Aaron Lisberg, MD; and Christine M. Lovly, MD, PhD, FASCO, discuss current and emerging treatment strategies targeting HER2 and TROP2 in patients with advance…

1
WHEN YOU HIT A WALL Let Music Change Your Path 36:18

7d ago36:18

36:18

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Jacy Dawn Valeras, Award-winning Television Host, Producer, Podcaster and Music Business Executive Hildy welcomes Jacy Dawn Valeras—television host, producer, music business executive, and podcaster with over 25 years of experience in the industry. Jacy shares her life-long dream of becoming a count…

1
Treatment Optimization and Management of AEs with EV + P for Untreated Locally Advanced/Metastatic Urothelial Cancer 40:32

7d ago40:32

40:32

In this podcast "Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast", authors discuss the management of adverse events (AEs) with enfortumab vedotin + pembrolizumab based on their personal experiences with clinical trials and in their practices …

1
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast 18:46

13d ago18:46

18:46

In this podcast, Dr. Zoe Apalla from the Aristotle University of Thessaloniki, Thessaloniki, Greece, and Dr. Katya Harfmann from the Nationwide Children’s Hospital, Columbus, OH, USA discuss tools for assessing alopecia areata severity, including the Severity of Alopecia Tool, AA Scale, and AA Severity and Morbidity Index. An interactive digital fe…

1
Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis 29:42

19d ago29:42

29:42

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-025-01491-2. All conflicts of interest can be found online. This podcast is intended for me…

1
S2 Ep47: Breast Cancer Tumor Board®: Advancing Care in Metastatic Breast Cancer—The Evolving Role of Antibody-Drug Conjugates 31:00

28d ago31:00

31:00

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Hope S. Rugo, MD; and Joyce O’Shaughnessy, MD, discuss pivotal trials of antibody-drug conjugates in HR+/HER2- and triple-negative subtypes of metastatic breast cancer. Learning Objectives Upon succ…

1
Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care 44:11

28d ago44:11

44:11

Ms Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer. NCPD information and select publications here.By Dr. Neil Love

1
S2 Ep45: Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies 30:53

28d ago30:53

30:53

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Vinay Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen Bagley, MD, MSCE; and Angela Waanders, MD, MPH, MS; discuss advancements in targeted therapies to treat adult and pediatric low- and high-gra…

1
S2 Ep35: Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma 28:30

28d ago28:30

28:30

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treatment options for relapsed/refractory multiple myeloma (R/R MM). Learning Objectives Upon successful completion of this ac…

1
S2 Ep42: Medical Crossfire®: Expert Perspectives on c-MET and MET Targeting in NSCLC—Unveiling the Complexities of MET Dysregulation 48:08

28d ago48:08

48:08

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting c-MET overexpression and MET genomic alterations in …

1
S2 Ep41: Cases & Conversations™: Transforming AML Care – Precision Strategies, Evolving Therapies, and Clinical Insights 17:15

28d ago17:15

17:15

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; and Amer Zeidan, MBBS, MHS; discuss current best practices and emerging strategies in acute myeloid leukemia (AML) management. Learni…

1
S2 Ep43: GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer 31:30

28d ago31:30

31:30

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Drs Stacey Cohen, Aparna Parikh, Kanwal Raghav, and John Strickler discuss advancements in targeted therapies to treat adult metastatic colorectal cancer. Learning Objectives Upon successful complet…

1
S2 Ep36: Medical Crossfire: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma 35:33

28d ago35:33

35:33

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treating and managing newly diagnosed multiple myeloma (NDMM). Learning Objectives Upon successful completion of this activity…

1
S2 Ep37: Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing 32:37

28d ago32:37

32:37

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Eileen O’Reilly, MD, and Brian Wolpin, MD, MPH, discuss current principles for molecular testing and emerging targeted therapy approaches for patients with metastatic pancreatic ductal adenocarcinom…

1
S2 Ep38: Show Me the Data™ New Frontiers in the Treatment of Ovarian Cancer 32:37

28d ago32:37

32:37

Thank you for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Rachel N. Grisham, MD; Oladapo O. Yeku, MD, PhD, FACP; and Ramez N. Eskander, MD, explore new frontiers in the treatment of ovarian cancer, including advances in biomarker-driven decision-making,…

1
S2 Ep40: Tumor Board: Expert Insights on Managing Classical EGFR Mutations, EGFR Exon 20 Insertions, and Atypical EGFR Mutations in Metastatic NSCLC 29:28

28d ago29:28

29:28

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; and Julia Rotow, MD; discuss the latest evidence in managing EGFR-mutated non–small cell lung cancer (NSCLC), with a focus on personalized treatment …

1
S2 Ep39: Medical Crossfire: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches 21:36

28d ago21:36

21:36

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gabriela Hobbs, MD; John O. Mascarenhas, MD; and Naveen Pemmaraju, MD; discuss recent advances in therapies for myelofibrosis (MF), polycythemia vera (PV), and essential thrombocytopenia (ET). Learn…

1
S2 Ep44: PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC – Expert Perspectives on New Approvals and Emerging Strategies 21:10

28d ago21:10

21:10

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; and Misty D. Shields, MD, PhD; discuss recent advances and emerging approaches—including immunotherapy, DLL3-targeted…

1
Talk of Hope | S1, Ep13: From stage 1 to 3b and back again [Jane Holmes] 1:04:55

30d ago1:04:55

1:04:55

Jane Holmes was 43, fit, and feeling fine when she was diagnosed with inoperable lung cancer. That was 11 years ago. In our latest Talk of Hope podcast, Jane shares how her determination, second opinions, and a surgeon willing to say "yes" helped her beat the odds – and change minds in the process.

1
Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches 53:51

1M ago53:51

53:51

Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. NCPD information and select publications here.By Dr. Neil Love

1
PROGRESS BRINGS HOPE FOR SMALL CELL LUNG CANCER 37:51

1M ago37:51

37:51

Voicing New Reasons for Optimism HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Maida Mangiameli, Dusty Donaldson, Misty Shields, MD, Ph.D., and Ann Steagall Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer with a 5-year survival rate of just 7%, a disheartening statistic. Despite this, survivors, researchers, and the med…

1
Talk of Hope | S1, Ep12: The Cancer Co-Pilot [Sarah Richards] 51:34

1M ago51:34

51:34

When lung cancer strikes, it doesn’t just hit the person diagnosed. It affects everyone close to them, too. In our latest Talk of Hope podcast, we chat to Sarah Richards about what it’s like to be a ‘cancer copilot’.

1
Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress 1:30:22

2M ago1:30:22

1:30:22

Dr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.…

1
DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress 1:27:39

2M ago1:27:39

1:27:39

Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.By Dr. Neil Love

1
Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress 1:26:53

2M ago1:26:53

1:26:53

Dr Christopher Flowers and Dr Manali Kamdar summarize the clinical treatment landscape for patients with non-Hodgkin lymphoma, supported by clinical perspectives and management strategies from nurse practitioners Ms Robin Klebig and Ms Caitlin Murphy. NCPD information and select publications here.By Dr. Neil Love

1
A Podcast on Real-World Evidence with Avelumab First-Line Maintenance and Treatment Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma 43:35

2M ago43:35

43:35

Avelumab first-line maintenance is an approved treatment for cisplatin-eligible or -ineligible patients with advanced urothelial carcinoma (UC) who are progression free following first-line platinum-based chemotherapy, based on the results of the... Avelumab first-line maintenance is an approved treatment for cisplatin-eligible or -ineligible patie…

1
Talk of Hope | S1, Ep11: Liquid Biopsy explained! 56:33

2M ago56:33

56:33

Back at the end of May, it was announced that NHS England are to roll out a pioneering blood test that could transform lung cancer treatment. In this episode, we chat through this latest new development with Professor Alastair Greystoke and guest co-host Yvonne Diaz and what it could mean for people with lung cancer.…

1
A Podcast on Integrating Genetic Testing for Homologous Recombination Repair Gene Alterations in Patients with Prostate Cancer in the USA: a Multidisciplinary Approach to Overcoming the Obstacles 21:19

2M ago21:19

21:19

In this podcast, Dr. Brittany M. Szymaniak from the Feinberg School of Medicine at Northwestern University, Chicago, IL, USA, Dr. Alicia K. Morgans from the Dana-Farber Cancer Institute, Boston, MA, USA, and Dr. Neal D. Shore from the Carolina... In this podcast, Dr. Brittany M. Szymaniak from the Feinberg School of Medicine at Northwestern Univers…

1
Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress 1:26:22

2M ago1:26:22

1:26:22

Dr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia. NCPD information and select publications here.By Dr. Neil Love

1
S2 Ep34: PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) 26:04

2M ago26:04

26:04

Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS Discus…

1
S2 Ep33: PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS) 24:46

2M ago24:46

24:46

Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Discuss the mechanisms of action, eff…

1
Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer 23:30

2M ago23:30

23:30

In this podcast, Dr. Danny Nguyen from the City of Hope, Huntington Beach, CA, USA, and Dr. Edgardo S. Santos from the Oncology Institute of Hope and Innovation, Broward County, FL, USA, aim to educate on strategies to mitigate and manage dermatologic... In this podcast, Dr. Danny Nguyen from the City of Hope, Huntington Beach, CA, USA, and Dr. Edg…

1
S2 Ep32: Breaking Barriers in HER2-Mutant NSCLC: Exploring the Promise of Next-Generation TKIs 26:11

2M ago26:11

26:11

Episode Description In this episode of the PER® podcast, we explore the evolving landscape of HER2-mutant non–small cell lung cancer (NSCLC)—a rare and historically difficult-to-treat subset of lung cancer. Join Millie Das, MD, from Stanford/VA Palo Alto; and Eric Kumar Singhi, MD, from The University of Texas MD Anderson Cancer Center; as they del…

1
Talk of Hope | S1, Ep10: Clinical Trials Explained [Ann Doran] 1:00:19

2M ago1:00:19

1:00:19

Clinical trials are crucial for the advancement of treatment, so we’ve been chatting to helpline nurse, Ann, about all things clinical trials. Listen now on our Talk of Hope podcast.

1
Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress 1:54:49

2M ago1:54:49

1:54:49

Drs Virginia F Borges and Seth Wander summarize the treatment landscape for patients with hormone receptor-positive breast cancer, supported with clinical perspectives and management strategies from nurse practitioners Ms Jamie Carroll and Mr Ronald Stein. NCPD information and select publications here.…

1
Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress 1:29:49

3M ago1:29:49

1:29:49

Dr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. NCPD information and select publications here.By Dr. Neil Love

1
ALL IN THE FAMILY Is Lung Cancer Inherited? 37:10

3M ago37:10

37:10

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUESTS: Jaclyn LoPiccolo, MD, Ph.D., Pasi Janne, MD, Ph.D., Dana Farber Cancer Institute and Jill Feldman, EGFR Resisters Hildy opens with a powerful anecdote about an early Upstage Lung Cancer Board member whose mother, grandmother, and aunt all had lung cancer. She endured months of allergy and antibioti…

1
S2 Ep31: Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies 1:04:32

3M ago1:04:32

1:04:32

Episode Description In this podcast, experts Andy Guinigundo, MSN, RN, CNP, ANP-BC, FAPO, and Fred Hirsch, MD, PhD, review the evolving treatment landscape for limited-stage small-cell lung cancer (LS-SCLC) and extensive-stage (ES) SCLC, including a discussion of the latest strategies for managing common and severe treatment-related adverse events.…

1
Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress 1:28:47

3M ago1:28:47

1:28:47

Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.…

1
Talk of Hope | S1, Ep9: Marathons and small cell lung cancer [Sean Kelly] 1:13:32

3M ago1:13:32

1:13:32

Today’s guest, Sean Kelly, has endured a very difficult few months since his small cell lung cancer diagnosis in February. He has also had to give up running which was a massive part of his life and a big passion. It’s all been a huge adjustment for him and he’s here today to tell us all about it.

1
Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress 1:33:16

3M ago1:33:16

1:33:16

Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.…

1
S2 Ep30: Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer 1:26:00

3M ago1:26:00

1:26:00

Episode Description This PER® Show Me Your Care Plan!™ featured podcast brings together two medical oncologists and an oncology nurse to discuss the latest advances in the management of platinum-resistant ovarian cancer (PROC). The expert panel reviews current and emerging therapies, with a special focus on the management of adverse events associat…

1
Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis

3M ago

—

Host: Jacob Sands, MD Guest: Elaine Shum, MD Guest: Estelamari Rodriguez, MD, MPH There was a recent pooled analysis of the TROPION-Lung01 and TROPION-Lung05 studies, which focused on the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients with previously treated EGFR-mutated advanced non-small cell lung cancer (NSCLC). According t…

1
Driving Best Practices Throughout the Treatment Journey for Patients with NSCLC with Actionable Alterations: A Podcast Discussion 38:06

3M ago38:06

38:06

· In this podcast, the authors discuss the current therapeutic landscape of NSCLC with actionable alterations and provide their perspectives on treatment algorithms, and how to optimally sequence therapies... · In this podcast, the authors discuss the current therapeutic landscape of NSCLC with actionable alterations and provide their perspectives …

1
Talk of Hope | S1, Ep8: Staying hopeful after progression [Jules Fielder] 48:18

3M ago48:18

48:18

Jules is living with stage 4 EGFR+ lung cancer, which had originally spread to her pelvis and spine. At the beginning of the year, Jules received the news that everyone with lung cancer fears. Her cancer had progressed. But in true Jules style, she’s still hopeful – got another holiday lined up – and here to talk as openly as ever about a very diff…

1
Increasing Awareness of Soft-Tissue Sarcoma: Podcast of a Patient–HCP Discussion 40:33

4M ago40:33

40:33

· In this podcast a patient with sarcoma and a specialist sarcoma nurse discuss the patient’s journey from initial diagnosis through to treatment and recovery. They will also discuss the physiological, emotional and mental... · In this podcast a patient with sarcoma and a specialist sarcoma nurse discuss the patient’s journey from initial diagnosis…

1
Prostate Cancer — Proceedings from the 2025 Annual ONS Congress 1:27:51

4M ago1:27:51

1:27:51

Dr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.By Dr. Neil Love

1
Living with ALK+: Diagnosis, Treatment, & Hope 33:55

4M ago33:55

33:55

A Biomarker Dialogue Between Patient and Scientist HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Marc Muskavitch, PhD, ALK+ & Zachary Rogers, PhD, Research Fellow, Koch Institute at MIT This episode features a powerful conversation between two scientists, one now navigating life as a Stage 4 ALK+ lung cancer patient. Most lung cancer patients o…

1
Talk of Hope | S1, Ep7: Lung cancer and travel insurance with Insurancewith [Fiona Macrae] 54:38

4M ago54:38

54:38

In this week’s Talk of Hope podcast, we cover the always hot topic of travel insurance (very appropriate after the mini heatwave gave us serious holiday vibes last week!) Joining us is Fiona Macrae, founder of Insurancewith. Fiona truly understands how difficult it can be for people withcancer to get insurance, especially those with a stage 4 diagn…

1
Talk of Hope | S1, Bonus Ep3: Post London Marathon 2025 special [Joe Gill, Khang Lê] 36:36

4M ago36:36

36:36

Less than a week ago, around 56,000 people took on the London Marathon in sweltering conditions. On this bonus episode of our Talk of Hope podcast, we caught up with two of our runners, Joe Gill and Khang Le to see how they got on.